Literature DB >> 22364940

Prevalence of extracranial venous abnormalities: results from a sample of 586 multiple sclerosis patients.

M Simka1, P Latacz, T Ludyga, M Kazibudzki, M Swierad, P Janas, J Piegza.   

Abstract

The aim of this study was to assess the prevalence of chronic cerebrospinal venous insufficiency in an unselected cohort of multiple sclerosis (MS) patients. A total of 586 patients with clinically defined MS underwent catheter venography of the internal jugular veins, brachiocephalic veins and azygos vein. The following findings were regarded as pathologic: no outflow, slowed outflow, reversal of flow direction, prestenotic dilation accompanied by impaired outflow, outflow through collaterals, intraluminal structures obstructing the vein, hypoplasia, agenesia or significant narrowing of the vein. Venous abnormalities were found in 563 patients (96.1%). Lesions in one vein were found in 43.5%, in two veins in 49.5%, and in three veins in 3.1% of patients. Venous pathologies in the right internal jugular vein were found in 64.0% of patients, in the left internal jugular vein in 81.7%, in the left brachiocephalic vein in 1.0%, and in the azygos vein in 4.9%. Venous pathologies were found to be highly associated with MS, yet the clinical relevance of this phenomenon remains to be established.

Entities:  

Mesh:

Year:  2011        PMID: 22364940      PMCID: PMC3814563     

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  30 in total

1.  Integrating CCSVI and CNS autoimmunity in a disease model for MS.

Authors:  A F Embry
Journal:  Int Angiol       Date:  2010-04       Impact factor: 2.789

2.  Regarding "no cerebrocervical venous congestion in patients with multiple sclerosis. Intraluminal jugular septation".

Authors:  Paolo Zamboni
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

3.  Transjugular liver biopsy: a retrospective analysis of 601 cases.

Authors:  Thomas Mammen; Shyamkumar N Keshava; C E Eapen; Lakshminarayan Raghuram; Vinu Moses; Kota Gopi; Narayanam Surendra Babu; Jeyamani Ramachandran; George Kurien
Journal:  J Vasc Interv Radiol       Date:  2008-03       Impact factor: 3.464

4.  Hemodynamic patterns of chronic cerebrospinal venous insufficiency in multiple sclerosis. Correlation with symptoms at onset and clinical course.

Authors:  I Bartolomei; F Salvi; R Galeotti; E Salviato; M Alcanterini; E Menegatti; M Mascalchi; P Zamboni
Journal:  Int Angiol       Date:  2010-04       Impact factor: 2.789

Review 5.  Venous collateral circulation of the extracranial cerebrospinal outflow routes.

Authors:  Paolo Zamboni; Giuseppe Consorti; Roberto Galeotti; Sergio Gianesini; Erica Menegatti; Giovanna Tacconi; Francesco Carinci
Journal:  Curr Neurovasc Res       Date:  2009-08-01       Impact factor: 1.990

6.  Anatomical variation of the internal jugular vein and its impact on temporary haemodialysis vascular access: an ultrasonographic survey in uraemic patients.

Authors:  B S Lin; C W Kong; D C Tarng; T P Huang; G J Tang
Journal:  Nephrol Dial Transplant       Date:  1998-01       Impact factor: 5.992

7.  Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe?

Authors:  T Ludyga; M Kazibudzki; M Simka; M Hartel; M Swierad; J Piegza; P Latacz; L Sedlak; M Tochowicz
Journal:  Phlebology       Date:  2010-12       Impact factor: 1.740

Review 8.  Reinterpreting the magnetic resonance signs of hemodynamic impairment in the brains of multiple sclerosis patients from the perspective of a recent discovery of outflow block in the extracranial veins.

Authors:  Marian Simka; Maciej Zaniewski
Journal:  J Neurosci Res       Date:  2010-07       Impact factor: 4.164

9.  A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency.

Authors:  Paolo Zamboni; Roberto Galeotti; Erica Menegatti; Anna Maria Malagoni; Sergio Gianesini; Ilaria Bartolomei; Francesco Mascoli; Fabrizio Salvi
Journal:  J Vasc Surg       Date:  2009-12       Impact factor: 4.268

10.  Multiple sclerosis, an unlikely cause of chronic cerebrospinal venous insufficiency: retrospective analysis of catheter venography.

Authors:  Marian Simka; Tomasz Ludyga; Marek Kazibudzki; Paweł Latacz; Marcin Swierad
Journal:  JRSM Short Rep       Date:  2012-08-17
View more
  6 in total

1.  Evaluating Necessity of Azygos Vein Ligation in Primary Repair of Esophageal Atresia.

Authors:  Mehdi Fathi; Marjan Joudi; Afsaneh Morteza
Journal:  Indian J Surg       Date:  2013-04-30       Impact factor: 0.656

2.  Mystery of chronic cerebrospinal venous insufficiency: identical venographic and ultrasound findings in patients with MS and controls.

Authors:  W McAuliffe; A G Kermode
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-31       Impact factor: 3.825

3.  Internal jugular vein entrapment in a multiple sclerosis patient.

Authors:  Marian Simka; Eugeniusz Majewski; Marek Fortuna; Maciej Zaniewski
Journal:  Case Rep Surg       Date:  2012-10-11

4.  Chronic cerebrospinal venous insufficiency in multiple sclerosis: a highly prevalent age-dependent phenomenon.

Authors:  Roberta Lanzillo; Marcello Mancini; Raffaele Liuzzi; Orlando Di Donato; Elena Salvatore; Valentina Maglio; Giovanni Vacca; Luca Amato; Gennaro D'Anna; Arturo Brunetti; Vincenzo Brescia Morra
Journal:  BMC Neurol       Date:  2013-02-13       Impact factor: 2.474

5.  Small internal jugular veins with restricted outflow are associated with severe multiple sclerosis: a sonographer-blinded, case-control ultrasound study.

Authors:  Željko Krsmanović; Maja Živković; Toplica Lepić; Aleksandra Stanković; Ranko Raičević; Evica Dinčić
Journal:  BMC Neurol       Date:  2013-07-17       Impact factor: 2.474

6.  Cross-sectional area variations of internal jugular veins during supine head rotation in multiple sclerosis patients with chronic cerebrospinal venous insufficiency: a prospective diagnostic controlled study with duplex ultrasound investigation.

Authors:  Massimiliano Farina; Eugenio Novelli; Raffaello Pagani
Journal:  BMC Neurol       Date:  2013-11-05       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.